Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-006999

Chief Business Officer acquired 11,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Loerop James · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-01 Exercise or conversion : show line 1 in the form +11,250 11,250 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-01 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +105,000 105,000 D
2023-02-01 Grant or award : show line 3 in the form Restricted Stock Units +30,000 30,000 D
2023-02-01 Exercise or conversion : show line 4 in the form Restricted Stock Units −11,250 33,750 D
Loading xslF345X03/doc4.xml…